Diffuse large B-cell lymphoma with overexpression of cyclin e substantiates poor standard treatment response and inferior outcome

DOI zum Zitieren dieses Dokuments:: 10.5283/epub.1946

Tzankov, Alexandar ; Gschwendtner, Andreas ; Augustin, Florian ; Fiegl, Michael ; Obermann, Ellen C. ; Dirnhofer, Stephan ; Went, Philip

PDF
(261kB) - Nur für Mitarbeiter des Archivs

Veröffentlichungsdatum dieses Volltextes: 05 Aug 2009 13:35

Alternative Links zum Volltext:DOI Pubmed Verlag

Details

Bibliographische Daten exportieren

Zusammenfassung

PURPOSE: Gold standard to predict survival and stratify patients for risk-adapted therapy in diffuse large B-cell lymphoma (DLBCL) is the international prognostic index, although it does not consider the molecular heterogeneity of DLBCL. Deregulation of cyclin E (CCNE) is a strong predictor of poor prognosis in some neoplastic diseases. In tumor cells, it induces chromosomal instability with an ...